Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$954M |
| 2 |
Salesforce
CRM
|
+$683M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$620M |
| 4 |
HCA Healthcare
HCA
|
+$560M |
| 5 |
Netflix
NFLX
|
+$445M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$861M |
| 2 |
Incyte
INCY
|
+$755M |
| 3 |
NVIDIA
NVDA
|
+$655M |
| 4 |
Charles Schwab
SCHW
|
+$534M |
| 5 |
MetLife
MET
|
+$373M |
Sector Composition
| 1 | Financials | 19.84% |
| 2 | Technology | 15.57% |
| 3 | Industrials | 8.44% |
| 4 | Healthcare | 8.44% |
| 5 | Energy | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLL
3601
DELISTED
Piedmont Lithium
PLL
| $417K | ﹤0.01% |
7,224
+295
| +4% | +$17K |
|
3602
Ryerson Holding
RYI
$723M
| $417K | ﹤0.01% |
9,595
+2,415
| +34% | +$105K |
|
3603
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $416K | ﹤0.01% |
10,156
-889
| -8% | -$36.4K |
|
3604
Tenaris
TS
$18.2B
| $416K | ﹤0.01% |
13,861
+6,729
| +94% | +$202K |
|
|
CIM
3605
Chimera Investment
CIM
$1.13B
| $415K | ﹤0.01% |
23,981
+4,016
| +20% | +$69.5K |
|
3606
NuScale Power
SMR
$6.26B
| $414K | ﹤0.01% |
60,771
+7,473
| +14% | +$50.9K |
|
|
IMGN
3607
DELISTED
Immunogen Inc
IMGN
| $413K | ﹤0.01% |
21,891
-41,041
| -65% | -$774K |
|
3608
Amplify Travel Tech ETF
AWAY
$42.7M
| $412K | ﹤0.01% |
24,207
+19,103
| +374% | +$325K |
|
3609
Astec Industries
ASTE
$1.09B
| $411K | ﹤0.01% |
9,057
+2,234
| +33% | +$101K |
|
|
GOOD
3610
Gladstone Commercial Corp
GOOD
$600M
| $411K | ﹤0.01% |
33,272
+3,301
| +11% | +$40.8K |
|
|
CNCR
3611
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
| $411K | ﹤0.01% |
31,818
+13,403
| +73% | +$173K |
|
3612
BlackRock MuniYield Fund
MYD
$485M
| $411K | ﹤0.01% |
39,357
-7,503
| -16% | -$78.4K |
|
3613
Ventyx Biosciences
VTYX
$164M
| $411K | ﹤0.01% |
12,553
+11,159
| +801% | +$365K |
|
3614
Adient
ADNT
$2B
| $410K | ﹤0.01% |
10,712
+5,194
| +94% | +$199K |
|
3615
Genco Shipping & Trading
GNK
$804M
| $410K | ﹤0.01% |
29,198
-50,873
| -64% | -$714K |
|
3616
Columbia Research Enhanced Core ETF
RECS
$3.73B
| $410K | ﹤0.01% |
+15,855
| New | +$410K |
|
|
HIX
3617
Western Asset High Income Fund II
HIX
$393M
| $408K | ﹤0.01% |
83,619
+1,135
| +1% | +$5.54K |
|
3618
Invesco AI and Next Gen Software ETF
IGPT
$562M
| $408K | ﹤0.01% |
11,361
-7,839
| -41% | -$282K |
|
3619
Utah Medical Products
UTMD
$199M
| $408K | ﹤0.01% |
4,377
+51
| +1% | +$4.75K |
|
3620
SLM Corp
SLM
$5.93B
| $407K | ﹤0.01% |
24,949
+4,316
| +21% | +$70.4K |
|
3621
TPG
TPG
$9.43B
| $406K | ﹤0.01% |
13,879
-1,099
| -7% | -$32.1K |
|
3622
Howard Hughes
HHH
$4.92B
| $405K | ﹤0.01% |
5,390
-21,913
| -80% | -$1.65M |
|
3623
Alight
ALIT
$1.77B
| $405K | ﹤0.01% |
43,823
+19,732
| +82% | +$182K |
|
3624
W&T Offshore
WTI
$261M
| $405K | ﹤0.01% |
104,816
+19,560
| +23% | +$75.6K |
|
3625
RadNet
RDNT
$5.88B
| $404K | ﹤0.01% |
12,384
+6,834
| +123% | +$223K |
|